Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cognizant Technology Solutions Corp (CTSH) vs Tilray Brands Inc (TLRY) Price & Performance

Cognizant Technology Solutions CorpTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Cognizant Technology Solutions Corp vs Tilray Brands Inc — how do they compare? Cognizant Technology Solutions Corp trades at $43.35 (market cap $20.34B), while Tilray Brands Inc trades at $4.38 (market cap $540.74M). The key difference: Cognizant Technology Solutions Corp is far larger — about 37.6× Tilray Brands Inc's market cap, and Cognizant Technology Solutions Corp pays a 3.07% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.

CTSHTLRY
Market Cap
$20.34B$540.74M
Sector
TechnologyHealth
52-Week High
$86.70$21.00
52-Week Low
$38.73$4.31
Enterprise Value
$19.92B$637.89M
Dividend Yield
3.07%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cognizant Technology Solutions Corp

Cognizant (CTSH) trades at $44.16, up 3.74% today, with a bullish technical signal and strong support at $44. The stock shows solid fundamentals with a P/E of 9.58, revenue of $21.11B in 2025, and consistent earnings beats. Recent news highlights AI partnerships with Google Cloud and OpenAI, positioning the company for growth in enterprise AI services.

The outlook is positive with a consensus price target of $63.45, implying significant upside. Risks include competitive pressures and macroeconomic softness affecting demand. Analyst sentiment is mixed but leans bullish, with 43% buy ratings. The stock presents a value opportunity given its low valuation multiples and strategic AI investments.

Tilray Brands Inc

TLRY trades at $4.46, up 0.9% on the day, amid a bearish technical signal and mixed earnings history. The company reported a net loss of $2.19 billion in 2025, with a negative net income margin of -156.67%, though revenue grew to $821.31 million. Analyst consensus is cautious with 65% hold ratings, and recent news highlights expansion in medical cannabis and new product launches.

The outlook remains challenged by persistent losses and high debt levels, but low valuation ratios like P/S of 0.54 and P/B of 0.35 may attract value investors. Key risks include profitability struggles and regulatory uncertainty, while potential catalysts include international expansion and upcoming earnings on July 28, 2026.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Cognizant Technology Solutions Corp

Cognizant is a global IT services provider, offering consulting and outsourcing services to some of the world's largest enterprises spanning the financial services, media and communications, healthcare, natural resources, and consumer products industries. Cognizant employs nearly 300,000 people globally, roughly 70% of whom are in India, although the company's headquarters are in Teaneck, New Jersey.

Read more on CTSH

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY